Skip to main content

Documentation Index

Fetch the complete documentation index at: https://docs.leveh.com/llms.txt

Use this file to discover all available pages before exploring further.

Trusted health and medical sources used in Leveh educational content

Leveh provides educational content and wellness support based on trusted public health and medical sources. This page lists the main references used to support educational information shown in the app, including medication information, weight management guidance, hydration, nutrition, physical activity, and safety topics. Leveh does not provide medical diagnosis, emergency care, or a substitute for treatment from a licensed healthcare professional. Always consult your doctor or qualified healthcare provider before starting, stopping, or changing any medication, dose, diet, or treatment plan.

How to use these references

The content in Leveh may include insights related to:
  • GLP-1 medications
  • weight management
  • hydration
  • nutrition
  • physical activity
  • side effects and medication safety
These insights are intended for educational and self-tracking purposes only. They should not be interpreted as individualized medical advice.

1. GLP-1 Medications

Leveh may reference official prescribing and safety information for GLP-1 and related weight-management medications. These sources are used to support educational content about indications, dosage schedules, warnings, precautions, and adverse reactions.

Wegovy Prescribing Information

Source: U.S. Food and Drug Administration (FDA)
Official prescribing information for semaglutide, including indication, dose escalation, contraindications, warnings, and adverse reactions. The FDA label states that Wegovy is indicated in combination with a reduced-calorie diet and increased physical activity.

Ozempic Prescribing Information

Source: U.S. Food and Drug Administration (FDA)
Official prescribing information for semaglutide, including boxed warning, contraindications, and safety precautions.

Zepbound Prescribing Information

Source: U.S. Food and Drug Administration (FDA)
Official prescribing information for tirzepatide, including indication, safety warnings, contraindications, and adverse reactions.

2. Weight Management

Leveh may present educational content related to long-term weight management, healthy lifestyle support, and the role of prescription treatment when appropriate. These references are used to support general educational information about obesity and overweight care.

Prescription Medications to Treat Overweight & Obesity

Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
NIDDK explains that the FDA has approved multiple prescription medications for chronic weight management, including semaglutide and tirzepatide.

Overweight and Obesity – Treatment

Source: National Heart, Lung, and Blood Institute (NHLBI), NIH
NHLBI explains that treatment plans often include reducing calorie intake, increasing physical activity, and adopting long-term healthy lifestyle changes.

3. Nutrition

Leveh may present educational content about healthy eating habits, food quality, fiber intake, meal balance, and sustainable nutrition behaviors. These references support general nutrition education only.

Dietary Guidelines for Americans, 2020–2025

Source: U.S. Department of Health and Human Services / U.S. Department of Agriculture
The Dietary Guidelines for Americans provide evidence-based recommendations on healthy dietary patterns and nutrient needs for the general population.

4. Hydration

Leveh may present educational reminders or summaries related to water intake and hydration. These references support general hydration education and do not replace professional medical care.

About Water and Healthier Drinks

Source: Centers for Disease Control and Prevention (CDC)
The CDC states that getting enough water every day is important for health, and that drinking water can help prevent dehydration, which may contribute to unclear thinking, mood changes, overheating, constipation, and kidney stones. The CDC also notes that replacing sugary drinks with water can help reduce calorie intake.

5. Physical Activity

Leveh may show educational content related to physical activity goals, movement habits, and exercise consistency as part of a broader wellness routine.

Adult Activity Guidelines

Source: Centers for Disease Control and Prevention (CDC)
The CDC states that adults need at least 150 minutes of moderate-intensity physical activity each week, or 75 minutes of vigorous-intensity activity, plus muscle-strengthening activity on 2 or more days per week.

6. Side Effects and Medication Safety

Leveh may show educational information about commonly reported side effects, medication safety, boxed warnings, precautions, and contraindications. Safety-related content is based on official prescribing information and public health references. Main safety references include:
  • Wegovy Prescribing Information — FDA
  • Ozempic Prescribing Information — FDA
  • Zepbound Prescribing Information — FDA
Users should always consult their own physician or licensed healthcare provider for decisions involving side effects, dose adjustments, treatment interruptions, or medication changes.

7. Important Notice

Leveh is designed to help users organize personal health and wellness information, follow routines, and access educational content. It is not intended to:
  • diagnose disease
  • prescribe treatment
  • replace physician supervision
  • provide emergency or urgent medical care
  • make individualized medical decisions on behalf of the user
If you have questions about your medication, symptoms, adverse reactions, or treatment plan, speak to your doctor or healthcare professional.

8. Third-Party Medical and Public Health Sources Used by Leveh

Leveh may rely on educational material and official prescribing documents from trusted institutions, including:
  • U.S. Food and Drug Administration (FDA)
  • Centers for Disease Control and Prevention (CDC)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH)
  • National Heart, Lung, and Blood Institute (NHLBI/NIH)
  • Dietary Guidelines for Americans

9. Reference List

For implementation on your site, use these official source pages:
Wegovy Prescribing Information (FDA)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf

Ozempic Prescribing Information (FDA)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s025lbl.pdf

Zepbound Prescribing Information (FDA)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217806s031lbl.pdf

Prescription Medications to Treat Overweight & Obesity (NIDDK)
https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity

Overweight and Obesity – Treatment (NHLBI)
https://www.nhlbi.nih.gov/health/overweight-and-obesity/treatment

Dietary Guidelines for Americans, 2020–2025
https://www.dietaryguidelines.gov/sites/default/files/2021-03/Dietary_Guidelines_for_Americans-2020-2025.pdf

About Water and Healthier Drinks (CDC)
https://www.cdc.gov/healthy-weight-growth/water-healthy-drinks/index.html

Adult Activity: An Overview (CDC)
https://www.cdc.gov/physical-activity-basics/guidelines/adults.html